Chimeric Antigen Receptor T-cell Therapy in Hematologic Malignancies and Patient-reported Outcomes: A Scoping Review.

导出 LinkOut

翻译打印收藏纠错

作者： Fabio,Efficace ^[1] ; Laura,Cannella ^[1] ; Francesco,Sparano ^[1] ; Johannes M,Giesinger ^[2] ; Marco,Vignetti ^[1] ; Frédéric,Baron ^[3] ; Eduardo,Bruera ^[4] ; Mario,Luppi ^[5] ; Uwe,Platzbecker ^[6]

作者单位： Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy. ^[1] University Hospital of Psychiatry II, Medical University of Innsbruck, Austria. ^[2] Department of Hematology, University and CHU of Liège, Belgium. ^[3] Palliative Care & Rehabilitation Medicine, UT M. D. Anderson Cancer Center, Houston, TX, USA. ^[4] Section of Hematology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Modena, Italy. ^[5] Department of Hematology and Cellular Therapy, Medical Clinic and Policlinic I, Leipzig University Hospital, Germany. ^[6]

DOI 10.1097/HS9.0000000000000802

PMID 36504547

发布时间 2023-02-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

HemaSphere

2022年6卷12期

e802页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Chimeric Antigen Receptor T-cell Therapy in Hematologic Malignancies and Patient-reported Outcomes: A Scoping Review.

HemaSphere

相似文献

HemaSphere

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Chimeric Antigen Receptor T-cell Therapy in Hematologic Malignancies and Patient-reported Outcomes: A Scoping Review.

HemaSphere

相似文献

HemaSphere

相关期刊

检索历史清除